Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 582 articles:
HTML format
Text format



Single Articles


    November 2017
  1. XIA Q, Ning Z, Torian LV
    Should we report the proportion of late HIV diagnoses?
    AIDS. 2017;31:2559-2561.
    PubMed     Text format    


  2. WU UI, Hung CC, Chang SY, Jhong YT, et al
    Neutralizing antiinterferon-gamma autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy.
    AIDS. 2017;31:2557-2559.
    PubMed     Text format    


  3. BRENNER BG, Baril JG
    Limiting cardiovascular events associated with HIV and antiretroviral therapy.
    AIDS. 2017;31:2551-2553.
    PubMed     Text format    


  4. DHARAN NJ, Cooper DA
    Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens.
    AIDS. 2017;31:2547-2549.
    PubMed     Text format    


  5. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.
    AIDS. 2017;31:2483-2492.
    PubMed     Text format     Abstract available


  6. MCGILLEN JB, Sharp A, Honermann B, Millett G, et al
    Consequences of a changing US strategy in the global HIV investment landscape.
    AIDS. 2017;31:F19-F23.
    PubMed     Text format     Abstract available


  7. GATELL JM, Assoumou L, Moyle G, Waters L, et al
    Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.
    AIDS. 2017;31:2503-2514.
    PubMed     Text format     Abstract available



  8. Frailty in HIV infected people: a new risk factor for bone mineral density loss?: Erratum.
    AIDS. 2017;31:2441.
    PubMed     Text format    


  9. SAH P, Fitzpatrick MC, Pandey A, Galvani AP, et al
    HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:2437-2439.
    PubMed     Text format    


  10. DALAL S, Johnson C, Fonner V, Kennedy CE, et al
    Reaching people with undiagnosed HIV infection through assisted partner notification.
    AIDS. 2017;31:2436-2437.
    PubMed     Text format    


  11. JOSEPH DAVEY DL, Wall KM
    Need to include couples' HIV counselling and testing as a strategy to improve HIV partner notification services.
    AIDS. 2017;31:2435-2436.
    PubMed     Text format    


  12. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
    AIDS. 2017;31:2355-2365.
    PubMed     Text format     Abstract available


  13. SIEFRIED KJ, Mao L, Cysique LA, Rule J, et al
    Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive ART.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001685.
    PubMed     Text format     Abstract available


  14. LODI S, Gunthard HF, Dunn D, Garcia F, et al
    Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692.
    PubMed     Text format     Abstract available


  15. MAKINSON A, Hayot M, Eymard-Duvernay S, Ribet C, et al
    HIV is associated with airway obstruction: a matched controlled study.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001691.
    PubMed     Text format     Abstract available


  16. MATHABIRE RUCKER SC, Tayea A, Bitilinyu-Bangoh J, Bermudez-Aza EH, et al
    High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients: results from a cross-sectional survey in Malawi.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001700.
    PubMed     Text format     Abstract available


  17. CHOMONT N, Okoye AA, Favre D, Trautmann L, et al
    Wake me up before you go: A strategy to reduce the latent HIV reservoir.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001695.
    PubMed     Text format     Abstract available


  18. TRIPLETTE M, Justice A, Attia EF, Tate J, et al
    Markers of Chronic Obstructive Pulmonary Disease are associated with mortality in people living with HIV.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001701.
    PubMed     Text format     Abstract available


  19. INZAULE SC, Hamers RL, Calis J, Boerma R, et al
    When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001696.
    PubMed     Text format     Abstract available


  20. FAVARATO G, Townsend CL, Bailey H, Peters H, et al
    Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001694.
    PubMed     Text format     Abstract available


  21. SHARMA M, Smith JA, Farquhar C, Ying R, et al
    Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya: A mathematical modeling analysis.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001697.
    PubMed     Text format     Abstract available


  22. PONGPIRUL W, Pongpirul K, Ananworanich J, Klinbuayaem V, et al
    Chronic kidney disease incidence and survival of Thai HIV-infected patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001698.
    PubMed     Text format     Abstract available


  23. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001699.
    PubMed     Text format     Abstract available


  24. AHMAD F, Mishra N, Ahrenstorf G, Franklin BS, et al
    Evidence of inflammasome activation and formation of monocyte-derived apoptosis-associated speck-like protein containing a caspase-recruitment domain specks in HIV-1 positive patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001693.
    PubMed     Text format     Abstract available


  25. MOCROFT A, Laut K, Reiss P, Gatell J, et al
    Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
    AIDS. 2017 Nov 3. doi: 10.1097/QAD.0000000000001684.
    PubMed     Text format     Abstract available


  26. EDWARDS JK, Cole SR, Hall HI, Mathews WC, et al
    Virologic suppression and CD4 cell count recovery after initiation of raltegravir- or efavirenz- containing HIV treatment regimens.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001668.
    PubMed     Text format     Abstract available


  27. BEIMA-SOFIE K, Wamalwa D, Maleche-Obimbo E, Lingappa JR, et al
    Toll-Like Receptor (TLR) 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001680.
    PubMed     Text format     Abstract available


  28. FORD N, Migone C, Calmy A, Kerschberger B, et al
    Benefits and risks of rapid initiation of antiretroviral therapy: a systematic review and meta-analysis.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001671.
    PubMed     Text format     Abstract available


  29. LAVENDER KJ, Pace C, Sutter K, Messer RJ, et al
    An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001674.
    PubMed     Text format     Abstract available


  30. NICOL MR, Brewers LM, Kashuba AD, Sykes C, et al
    The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001678.
    PubMed     Text format     Abstract available


  31. BOIVIN MJ, Barlow-Mosha L, Chernoff M, Laughton B, et al
    Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001683.
    PubMed     Text format     Abstract available


  32. CID-SILVA P, Margusino-Framinan L, Balboa-Barreiro V, Martin-Herranz I, et al
    Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001679.
    PubMed     Text format     Abstract available


  33. CARRILLO J, Negredo E, Puig J, Molinos-Albert LM, et al
    Memory B cell dysregulation in HIV-1 infected Individuals.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001686.
    PubMed     Text format     Abstract available


  34. CANIGLIA EC, Zash R, Jacobson DL, Diseko M, et al
    Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001673.
    PubMed     Text format     Abstract available


  35. LONGENECKER CT, Sullivan CE, Morrison J, Hileman CO, et al
    The effects of HIV and smoking on aortic and splenic inflammation.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001682.
    PubMed     Text format     Abstract available


  36. BARDON VF, Mandelbrot L, Duro D, Dussaux C, et al
    Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001681.
    PubMed     Text format     Abstract available


  37. BURLACU R, Umlauf A, Luca A, Gianella S, et al
    Sex based differences in neurocognitive functioning in HIV infected young adults.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001687.
    PubMed     Text format     Abstract available


  38. ENGELHARD EAN, Smit C, Van Dijk PR, Kuijper TM, et al
    Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseasess.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001672.
    PubMed     Text format     Abstract available


  39. OLSON A, Bannert N, Sonnerborg A, de Mendoza C, et al
    Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001689.
    PubMed     Text format     Abstract available


    October 2017
  40. TARTAGLIA A, Ferrara SM, Sica S, Santantonio T, et al
    Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.
    AIDS. 2017;31:2314-2315.
    PubMed     Text format    


  41. VASE MO, Ludvigsen M, Bendix K, Dutoit SH, et al
    Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
    AIDS. 2017;31:2311-2313.
    PubMed     Text format    


  42. SIEGENBEEK VAN HEUKELOM ML, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017;31:2295-2301.
    PubMed     Text format     Abstract available


  43. TASSIOPOULOS K, Abdo M, Wu K, Koletar SL, et al
    Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.
    AIDS. 2017;31:2287-2294.
    PubMed     Text format     Abstract available


  44. MIKKELSEN E, Hontelez JAC, Nonvignon J, Amon S, et al
    The costs of HIV treatment and care in Ghana.
    AIDS. 2017;31:2279-2286.
    PubMed     Text format     Abstract available


  45. MENZA TW, Billock R, Samoff E, Eron JJ, et al
    Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.
    AIDS. 2017;31:2235-2244.
    PubMed     Text format     Abstract available


  46. HOORNENBORG E, Krakower DS, Prins M, Mayer KH, et al
    Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.
    AIDS. 2017;31:2179-2191.
    PubMed     Text format     Abstract available


  47. LEVINSON KL, Riedel DJ, Ojalvo LS, Chan W, et al
    Gynecologic cancer in HIV infected women: treatment and outcomes in a multi-institutional cohort.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001664.
    PubMed     Text format     Abstract available


  48. SABIN CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, et al
    Abacavir use and risk of recurrent myocardial infarction: the D: A: D Study.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001666.
    PubMed     Text format     Abstract available


  49. VICENZI E, Poli G
    Chronically infected T Cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001655.
    PubMed     Text format    


  50. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    PubMed     Text format     Abstract available


  51. CREPAZ N, Tang T, Marks G, Hall HI, et al
    Changes in viral suppression status among HIV patients receiving care: United States, 2014.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001660.
    PubMed     Text format     Abstract available


  52. NISHIJIMA T, Mutoh Y, Kawasaki Y, Tomonari K, et al
    Cumulative exposure of tenofovir disoproxil fumarate is associated with kidney tubulopathy whether it is currently used or discontinued in HIV-infected patients.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001667.
    PubMed     Text format     Abstract available


  53. SANDERS EJ, Price MA, Karita E, Kamali A, et al
    Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001659.
    PubMed     Text format     Abstract available


  54. STAFFORD KA, Magder LS, Hungerford LL, Guralnik JM, et al
    Immunologic response to ART by age among treatment-naive patients in sub-Saharan Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001663.
    PubMed     Text format     Abstract available


  55. GOPALAPPA C, Sansom SL, Farnham PG, Chen YH, et al
    Combinations of interventions to achieve a national HIV incidence reduction goal: insights from the agent-based PATH 2.0 model.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001653.
    PubMed     Text format     Abstract available


  56. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with a one-year follow-up.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001658.
    PubMed     Text format     Abstract available


  57. ROCHA C, Duarte J, Borrego P, Calado R, et al
    Potency of HIV-2-specific antibodies increase in direct association with loss of memory B-cells.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001661.
    PubMed     Text format     Abstract available


    September 2017
  58. ZOBOLI F, Ripamonti D, Benatti SV, Comi L, et al
    Autoimmune hepatitis and HIV infection: two case reports and review of the literature.
    AIDS. 2017;31:2172-2175.
    PubMed     Text format    


  59. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    AIDS. 2017;31:2135-2145.
    PubMed     Text format     Abstract available


  60. LAKE AC
    Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.
    AIDS. 2017;31:2115-2118.
    PubMed     Text format     Abstract available


  61. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017;31:2059-2067.
    PubMed     Text format     Abstract available


  62. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardized definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017;31:2053-2058.
    PubMed     Text format    


  63. JAO J, Powis KM, Kirmse B, Yu C, et al
    Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001647.
    PubMed     Text format     Abstract available


  64. BESSON C, Lancar R, Prevot S, Algarte-Genin M, et al
    Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001652.
    PubMed     Text format     Abstract available


  65. EWING AC, King CC, Wiener JB, Chasela CS, et al
    Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001641.
    PubMed     Text format     Abstract available


  66. SCHEEPERS C, Chowdhury S, Wright WS, Campbell CT, et al
    Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001643.
    PubMed     Text format     Abstract available


  67. ANGELOVICH TA, Hearps AC, Oda MN, Borja MS, et al
    Dysfunctional HDL from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001642.
    PubMed     Text format     Abstract available


  68. VAN HEUKELOM MLS, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal HSIL in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001639.
    PubMed     Text format     Abstract available


  69. CHOW FC, Regan S, Zanni MV, Looby SE, et al
    Elevated ischemic stroke risk among women living with HIV infection.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001650.
    PubMed     Text format     Abstract available


  70. LAKE JE, Li X, Palella FJ Jr, Erlandson KM, et al
    Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001651.
    PubMed     Text format     Abstract available


  71. RODRIGUEZ-HART C, Nowak RG, Musci R, German D, et al
    Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001637.
    PubMed     Text format     Abstract available


  72. DUQUENNE C, Gimenez S, Guigues A, Viala B, et al
    Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001649.
    PubMed     Text format     Abstract available


  73. THORNTON AC, Jose S, Bhagani S, Chadwick D, et al
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646.
    PubMed     Text format     Abstract available


  74. MIKULAK J, Oriolo F, Zaghi E, Di Vito C, et al
    Natural Killer cells in HIV-1 infection and therapy.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.
    PubMed     Text format     Abstract available


  75. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001648.
    PubMed     Text format     Abstract available


  76. BALASUBRAMANIAN R, Fowler MG, Dominguez K, Lockman S, et al
    Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001640.
    PubMed     Text format     Abstract available


  77. FLORES HERRERA MF, Dauby N
    Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: is there a link?
    AIDS. 2017;31:2024-2025.
    PubMed     Text format    


  78. KLATT NR, Hunt PW
    MicroRNAs: novel tools to block gut inflammation in HIV?
    AIDS. 2017;31:2017-2018.
    PubMed     Text format    


  79. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS. 2017;31:1979-1988.
    PubMed     Text format     Abstract available


  80. RONIT A, Kristensen T, Klitbo DM, Gelpi M, et al
    Incidental lung cancers and positive computed tomography images in people living with HIV.
    AIDS. 2017;31:1973-1977.
    PubMed     Text format     Abstract available


    August 2017
  81. WEINSTEIN M, Yang OO, Cohen AC
    Were we prepared for PrEP? five years of implementation.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001626.
    PubMed     Text format     Abstract available


  82. MEDLAND NA, Nicholson S, Chow EPF, Read THR, et al
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001634.
    PubMed     Text format     Abstract available


  83. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Text format     Abstract available


  84. ORLOVA-FINK N, Chowdhury FZ, Xiaoming S, Harrington S, et al
    Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001630.
    PubMed     Text format     Abstract available


  85. RUBIN LH, Cook JA, Springer G, Weber KM, et al
    Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001625.
    PubMed     Text format     Abstract available


  86. BOCCARA F, Ghislain M, Meyer L, Goujard C, et al
    Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from the ANRS COPANA cohort.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001633.
    PubMed     Text format     Abstract available


  87. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001628.
    PubMed     Text format     Abstract available


  88. MCCLELLAND A, French M, Mykhalovskiy E, Gagnon M, et al
    The harms of HIV criminalization: responding to the 'association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:1899-1900.
    PubMed     Text format    


  89. GOLDEN MR
    Assisted partner services for HIV: ready to go global.
    AIDS. 2017;31:1891-1893.
    PubMed     Text format    


  90. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
    AIDS. 2017;31:1885-1889.
    PubMed     Text format     Abstract available


  91. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS. 2017;31:1859-1866.
    PubMed     Text format     Abstract available


  92. SALADINI F, Giannini A, Boccuto A, Tiezzi D, et al
    The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001616.
    PubMed     Text format     Abstract available


  93. GANDHI M, Murnane PM, Bacchetti P, Elion R, et al
    Hair Levels of PrEP Drugs Measure Adherence and are Associated with Renal Decline Among Men/Transwomen in an Open Label PrEP Study.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001615.
    PubMed     Text format     Abstract available


  94. FOURMAN LT, Czerwonka N, Feldpausch MN, Weiss J, et al
    Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001614.
    PubMed     Text format     Abstract available


  95. MILLS JC, Harman JS, Cook RL, Marlow NM, et al
    Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001618.
    PubMed     Text format     Abstract available


  96. ANDERSON JC, Grace KT, Miller E
    Reproductive coercion among women living with HIV: an unexplored risk factor for negative sexual and mental health outcomes.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001620.
    PubMed     Text format     Abstract available


  97. LEE GQ, Bangsberg DR, Mo T, Lachowski C, et al
    Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001619.
    PubMed     Text format     Abstract available


  98. YIN MT, Chan ES, Brown TT, Tebas P, et al
    Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation: ACTG A5280.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001621.
    PubMed     Text format     Abstract available


  99. MENZA TW, Billock R, Samoff E, Eron JJ, et al
    Pre-treatment integrase strand transfer inhibitor resistance in north carolina from 2010-2016.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001611.
    PubMed     Text format     Abstract available


  100. TASSIOPOULOS K, Abdo M, Wu K, Koletar SL, et al
    Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults: a prospective cohort study.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001613.
    PubMed     Text format     Abstract available


  101. MIKKELSEN E, Hontelez J, Nonvignon J, Amon S, et al
    The costs of HIV treatment and care in Ghana: A longitudinal multi-site analysis.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001612.
    PubMed     Text format     Abstract available


  102. BERARD A, Sheehy O, Zhao JP, Abrahamowicz M, et al
    Antiretroviral combination use during pregnancy and the risk of major congenital malformations.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001610.
    PubMed     Text format     Abstract available


    July 2017
  103. SARIS J, van den Berk G, Moha DA, van der Meer J, et al
    Successful implementation of hepatitis C virus treatment in two large HIV clinics in Amsterdam: hepatitis C virus treatment cascade of care.
    AIDS. 2017;31:1779-1780.
    PubMed     Text format    


  104. SMIT DP, Meyer D
    HIV-induced uveitis: would you recognize it if it looked straight at you?
    AIDS. 2017;31:1777-1779.
    PubMed     Text format    


  105. KHELOUFI F, Boucherie Q, Blin O, Micallef J, et al
    Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.
    AIDS. 2017;31:1775-1777.
    PubMed     Text format    


  106. LAL L, Audsley J, Murphy DA, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users.
    AIDS. 2017;31:1709-1714.
    PubMed     Text format     Abstract available


  107. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.
    AIDS. 2017;31:1697-1707.
    PubMed     Text format     Abstract available


  108. CABY F
    CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
    AIDS. 2017;31:1685-1695.
    PubMed     Text format     Abstract available


  109. BISSON GP, Ramchandani R, Miyahara S, Mngqibisa R, et al
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS. 2017 Jul 24. doi: 10.1097/QAD.0000000000001606.
    PubMed     Text format     Abstract available


  110. BURGOS J, Hernandez-Losa J, Landolfi S, Guelar A, et al
    The role of oncogenic HPV determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001605.
    PubMed     Text format     Abstract available


  111. LEBRUN D, Hentzien M, Cuzin L, Rey D, et al
    Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001603.
    PubMed     Text format     Abstract available


  112. PRICE JC, Dodge JL, Ma Y, Scherzer R, et al
    Controlled attenuation parameter and MR spectroscopy-measured liver steatosis are discordant in HIV-infected adults with high body mass.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001601.
    PubMed     Text format     Abstract available


  113. DAVEY DLJ, Bekker LG, Gorbach P, Coates T, et al
    Delivering PrEP to pregnant and breastfeeding women in sub-Saharan africa: The implementation science frontier.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001604.
    PubMed     Text format     Abstract available


  114. AGUDELO-HERNANDEZ A, Chen Y, Bullotta A, Buchanan WG, et al
    Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001602.
    PubMed     Text format     Abstract available


  115. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardised definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001597.
    PubMed     Text format    


  116. DITTMER DP, Tamburro K, Chen H, Lee A, et al
    Oral shedding of Herpesviruses in HIV+ patients with varying degrees of immune status.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001589.
    PubMed     Text format     Abstract available


  117. HAALAND RE, Martin A, Holder A, Fountain JJ, et al
    Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis.
    AIDS. 2017;31:1647-1650.
    PubMed     Text format    


  118. RONIT A, Ahlstrom MG
    Publication trends during the HIV pandemic: contributions by country.
    AIDS. 2017;31:1646-1647.
    PubMed     Text format    


  119. MORSE CG
    Fatty liver disease in HIV: common, underappreciated, and understudied.
    AIDS. 2017;31:1633-1635.
    PubMed     Text format    


  120. HOORNENBORG E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, et al
    MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
    AIDS. 2017;31:1603-1610.
    PubMed     Text format     Abstract available


  121. RUPEREZ M, Gonzalez R, Maculuve S, Quinto L, et al
    Maternal HIV infection is an important health determinant in non-HIV-infected infants.
    AIDS. 2017;31:1545-1553.
    PubMed     Text format     Abstract available


  122. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017;31:1519-1528.
    PubMed     Text format     Abstract available


  123. ZENG H, Wang L, Liu P, Liao L, et al
    Seroprevalence of hepatitis E virus in HIV-infected patients in China.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001585.
    PubMed     Text format     Abstract available


  124. PHILIBERT P, Chiche L, Cailleres S, Allemand J, et al
    HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001588.
    PubMed     Text format     Abstract available


  125. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    PubMed     Text format     Abstract available


  126. STONER MCD, Pettifor A, Edwards JK, Aiello AE, et al
    The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001584.
    PubMed     Text format     Abstract available


  127. MCBAIN RK, Petersen E, Tophof N, Dunbar E, et al
    Impact and economic evaluation of a novel HIV service delivery model in rural Malawi.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001578.
    PubMed     Text format     Abstract available


  128. DONNELL D, Ramos E, Celum C, Baeten J, et al
    The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001577.
    PubMed     Text format     Abstract available


  129. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001586.
    PubMed     Text format     Abstract available


  130. FULCHER JA, Koukos G, Koutsioumpa M, Elliott J, et al
    Unique microRNA Expression in the Colonic Mucosa During Chronic HIV-1 Infection.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001582.
    PubMed     Text format     Abstract available


  131. SINGH KP, Crane M, Audsley J, Lewin SR, et al
    HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001574.
    PubMed     Text format     Abstract available


  132. LEMOINE M, Lacombe K, Bastard JP, Sebire M, et al
    Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: results of the METAFIB study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001587.
    PubMed     Text format     Abstract available


  133. HONG JJ, Silveira ELV, Amancha PK, Byrareddy SN, et al
    Early initiation of antiretroviral treatment post SIV infection does not resolve lymphoid tissue activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001576.
    PubMed     Text format     Abstract available


  134. VIEIRA VA, Avelino-Silva VI, Cerqueira NB, Costa DA, et al
    Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T cell activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001580.
    PubMed     Text format     Abstract available


  135. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of CMV and EBV replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001579.
    PubMed     Text format     Abstract available


  136. SUN B, Dalvi P, Abadjian L, Tang N, et al
    Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001595.
    PubMed     Text format     Abstract available


  137. ELZI L, Erb S, Furrer H, Cavassini M, et al
    Adverse events of raltegravir and dolutegravir: a prospective analysis of 4,041 HIV-infected individuals from the Swiss HIV Cohort Study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001590.
    PubMed     Text format     Abstract available


  138. LAFLEUR J, Bress AP, Rosenblatt L, Crook J, et al
    Cardiovascular outcomes among HIV-infected veterans receiving atazanavir: a US national historical cohort study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001594.
    PubMed     Text format     Abstract available


  139. CHAPPELL CA, Lamorde M, Nakalema S, Chen B, et al
    Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001591.
    PubMed     Text format     Abstract available


  140. VANHOMMERIG JW, Bezemer D, Molenkamp R, Van Sighem AI, et al
    Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001592.
    PubMed     Text format     Abstract available


  141. GROSS R, Bellamy SL, Ratshaa B, Han X, et al
    CYP2B6 genotypes and early efavirenz-based hiv treatment outcomes in botswana.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001593.
    PubMed     Text format     Abstract available


  142. CAMACHO-GONZALEZ AF, Gillespie SE, Thomas-Seaton L, Frieson K, et al
    The Metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, Georgia, USA.
    AIDS. 2017;31 Suppl 3:S267-S275.
    PubMed     Text format     Abstract available


  143. MARANO MR, Stein R, Williams WO, Wang G, et al
    HIV testing in nonhealthcare facilities among adolescent MSM.
    AIDS. 2017;31 Suppl 3:S261-S265.
    PubMed     Text format     Abstract available


  144. RURIA EC, Masaba R, Kose J, Woelk G, et al
    Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection.
    AIDS. 2017;31 Suppl 3:S253-S260.
    PubMed     Text format     Abstract available


  145. WAGNER AD, Mugo C, Bluemer-Miroite S, Mutiti PM, et al
    Continuous quality improvement intervention for adolescent and young adult HIV testing services in Kenya improves HIV knowledge.
    AIDS. 2017;31 Suppl 3:S243-S252.
    PubMed     Text format     Abstract available


  146. KAUFMAN MR, Dam KH, Van Lith LM, Hatzold K, et al
    Voluntary medical male circumcision among adolescents: a missed opportunity for HIV behavioral interventions.
    AIDS. 2017;31 Suppl 3:S233-S241.
    PubMed     Text format     Abstract available


  147. SHANAUBE K, Schaap A, Chaila MJ, Floyd S, et al
    Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study.
    AIDS. 2017;31 Suppl 3:S221-S232.
    PubMed     Text format     Abstract available


  148. WILSON KS, Beima-Sofie KM, Moraa H, Wagner AD, et al
    "At our age, we would like to do things the way we want: " a qualitative study of adolescent HIV testing services in Kenya.
    AIDS. 2017;31 Suppl 3:S213-S220.
    PubMed     Text format     Abstract available


  149. INDRAVUDH PP, Sibanda EL, d'Elbee M, Kumwenda MK, et al
    'I will choose when to test, where I want to test': investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe.
    AIDS. 2017;31 Suppl 3:S203-S212.
    PubMed     Text format     Abstract available


  150. DENISON JA, Pettifor A, Mofenson LM, Kasedde S, et al
    Youth engagement in developing an implementation science research agenda on adolescent HIV testing and care linkages in sub-Saharan Africa.
    AIDS. 2017;31 Suppl 3:S195-S201.
    PubMed     Text format     Abstract available


  151. WONG VJ, Murray KR, Phelps BR, Vermund SH, et al
    Adolescents, young people, and the 90-90-90 goals: a call to improve HIV testing and linkage to treatment.
    AIDS. 2017;31 Suppl 3:S191-S194.
    PubMed     Text format     Abstract available


    June 2017
  152. LEE JS, Cole SR, Richardson DB, Dittmer DP, et al
    Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001573.
    PubMed     Text format     Abstract available


  153. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing PMTCT regimens.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001569.
    PubMed     Text format     Abstract available


  154. GATANAGA H, Brumme ZL, Adland E, Reyes-Teran G, et al
    Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001575.
    PubMed     Text format     Abstract available


  155. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of post-migration HIV acquisition within nine European countries.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001571.
    PubMed     Text format     Abstract available


  156. RAWAL S, Bogoch II
    Evaluation of non-sexual, non-needlestick, non-occupational HIV post-exposure prophylaxis cases.
    AIDS. 2017;31:1500-1502.
    PubMed     Text format    


  157. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.
    AIDS. 2017;31:1489-1493.
    PubMed     Text format     Abstract available


  158. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:1471-1481.
    PubMed     Text format     Abstract available


  159. MCGRATH N, Grapsa E
    Does antiretroviral therapy change partnership dynamics and HIV risk behaviours among HIV-infected adults.
    AIDS. 2017;31:1451-1460.
    PubMed     Text format     Abstract available


  160. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma.
    AIDS. 2017;31:1445-1449.
    PubMed     Text format     Abstract available


  161. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV- men.
    AIDS. 2017;31:1435-1443.
    PubMed     Text format     Abstract available


  162. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.
    AIDS. 2017;31:1365-1378.
    PubMed     Text format     Abstract available


  163. WAGNER AD, Njuguna IN, Andere R, Cranmer LM, et al
    Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001562.
    PubMed     Text format     Abstract available


  164. FOSTER C, Pace M, Kaye S, Hopkins E, et al
    Early antiretroviral therapy reduces hiv dna following perinatal HIV infection.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001565.
    PubMed     Text format     Abstract available


  165. GONCALVES PH, Uldrick TS, Yarchoan R
    HIV-associated Kaposi sarcoma and related diseases.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001567.
    PubMed     Text format     Abstract available


  166. BASS JK, Opoka R, Familiar I, Nakasujja N, et al
    Randomized controlled trial of caregiver training for HIV-infected child neurodevelopment and caregiver well-being.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001563.
    PubMed     Text format     Abstract available


  167. GARCIA-KNIGHT MA, Nduati E, Hassan AS, Nkumama I, et al
    Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001568.
    PubMed     Text format     Abstract available


  168. WILLIAMS-WIETZIKOSKI CA, So ID, Bull ME, Samleerat T, et al
    Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals.
    AIDS. 2017 Jun 6. doi: 10.1097/QAD.0000000000001550.
    PubMed     Text format     Abstract available


  169. HARPER KN
    A decade of learning about the hiv reservoir: new insights into latent infection.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001559.
    PubMed     Text format    


  170. MONTSERRAT M, Plana M, Guardo AC, Andres C, et al
    Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001560.
    PubMed     Text format     Abstract available


  171. DIRAJLAL-FARGO S, Sattar A, Kulkarni M, Bowman E, et al
    HIV positive youth who are perinatally infected have impaired endothelial function.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001556.
    PubMed     Text format     Abstract available


  172. THOMPSON CG, Fallon JK, Mathews M, Charlins P, et al
    Multimodal analysis of drug transporter expression in gastrointestinal tissue.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001554.
    PubMed     Text format     Abstract available


  173. JEAN-PHILIPPE P, Spiegel H, Gnanashanmugam D, Fitzgibbon J, et al
    HIV birth testing and linkage to care for HIV infected infants: workshop synopsis.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001561.
    PubMed     Text format     Abstract available


  174. ERLANDSON KM, Fiorillo S, Masawi F, Scherzinger A, et al
    Antiretroviral initiation is associated with increased skeletal muscle area and fat content.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001558.
    PubMed     Text format     Abstract available


  175. AKULLIAN A, Bershteyn A, Klein D, Vandormael A, et al
    Sexual partnership age-pairings and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001553.
    PubMed     Text format     Abstract available


  176. BYRNE L, Sconza R, Foster C, Tookey PA, et al
    Pregnancy incidence and outcomes in women with perinatal HIV infection.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001552.
    PubMed     Text format     Abstract available


  177. DALAL S, Johnson C, Fonner V, Kennedy CE, et al
    Assisted HIV partner notification services: a systematic review and meta-analysis.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001555.
    PubMed     Text format     Abstract available


  178. DALLA PRIA A, Merchant S, Bower M
    Oncological challenges for an ageing population living with HIV.
    AIDS. 2017;31 Suppl 2:S185-S189.
    PubMed     Text format     Abstract available


  179. SMITH JM, Flexner C
    The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    AIDS. 2017;31 Suppl 2:S173-S184.
    PubMed     Text format     Abstract available


  180. NIGHTINGALE S, Winston A
    Measuring and managing cognitive impairment in HIV.
    AIDS. 2017;31 Suppl 2:S165-S172.
    PubMed     Text format     Abstract available


  181. BOCCARA F
    Cardiovascular health in an aging HIV population.
    AIDS. 2017;31 Suppl 2:S157-S163.
    PubMed     Text format     Abstract available


  182. GUARALDI G, Lonardo A, Maia L, Palella FJ Jr, et al
    Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver.
    AIDS. 2017;31 Suppl 2:S147-S156.
    PubMed     Text format     Abstract available


  183. HAWKINS KL, Brown TT, Margolick JB, Erlandson KM, et al
    Geriatric syndromes: new frontiers in HIV and sarcopenia.
    AIDS. 2017;31 Suppl 2:S137-S146.
    PubMed     Text format     Abstract available


  184. GUARALDI G, Palella FJ Jr
    Clinical implications of aging with HIV infection: perspectives and the future medical care agenda.
    AIDS. 2017;31 Suppl 2:S129-S135.
    PubMed     Text format     Abstract available


  185. SABIN CA, Reiss P
    Epidemiology of ageing with HIV: what can we learn from cohorts?
    AIDS. 2017;31 Suppl 2:S121-S128.
    PubMed     Text format     Abstract available


  186. LAGATHU C, Cossarizza A, Bereziat V, Nasi M, et al
    Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.
    AIDS. 2017;31 Suppl 2:S105-S119.
    PubMed     Text format     Abstract available


  187. TODESCO E, Demeret S, Calin R, Roque-Afonso AM, et al
    Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
    AIDS. 2017;31:1346-1348.
    PubMed     Text format    


  188. MCMAHON JH, Chang J, Tennakoon S, Dantanarayana A, et al
    Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.
    AIDS. 2017;31:1344-1346.
    PubMed     Text format    


  189. ESSER S, Streeck H
    Preexposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1344.
    PubMed     Text format    


  190. FOX J, Collins S
    HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1343.
    PubMed     Text format    


  191. MARSHALL BDL, Tate JP, McGinnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity.
    AIDS. 2017;31:1313-1321.
    PubMed     Text format     Abstract available


  192. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017;31:1261-1270.
    PubMed     Text format     Abstract available


  193. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    AIDS. 2017;31:1223-1234.
    PubMed     Text format     Abstract available


  194. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.
    PubMed     Text format    


    May 2017
  195. ROUGH K, Sun JW, Seage GR 3rd, Williams PL, et al
    Zidovudine use in pregnancy and congenital malformations: meta-analysis and Bayesian incorporation of medicaid data.
    AIDS. 2017 May 23. doi: 10.1097/QAD.0000000000001549.
    PubMed     Text format     Abstract available


  196. ALVAREZ A, Orden S, Andujar I, Collado-Diaz V, et al
    Cardiovascular toxicity of Abacavir: a clinical controversy in need of a pharmacological explanation.
    AIDS. 2017 May 23. doi: 10.1097/QAD.0000000000001547.
    PubMed     Text format     Abstract available


  197. TOBIN SC
    Recent Progress in Anti-HIV Broadly Neutralizing Antibody Research.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001544.
    PubMed     Text format    


  198. O'MALLEY TK, Burdo TH, Robinson JA, Fitch KV, et al
    Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001545.
    PubMed     Text format     Abstract available


  199. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in anti-retroviral therapy persistence among US medicaid beneficiaries, 2001-2010.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001541.
    PubMed     Text format     Abstract available


  200. RASMUSSEN TA, McMahon J, Chang JJ, Symons J, et al
    Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001540.
    PubMed     Text format     Abstract available


  201. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001546.
    PubMed     Text format     Abstract available


  202. ALSAN M, Beshears J, Armstrong WS, Choi JJ, et al
    A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001543.
    PubMed     Text format     Abstract available


  203. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    PubMed     Text format     Abstract available


  204. GATHOGO EN, Shah S, Post FA
    Kidney transplant outcomes in HIV serodiscordant recipient pairs.
    AIDS. 2017;31:1199-1201.
    PubMed     Text format    


  205. ORIKIIRIZA J, Nakawesi J, Kikaire B, Turitwenka D, et al
    Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda.
    AIDS. 2017;31:1196-1199.
    PubMed     Text format    


  206. AL TABAA O, Audren V, Hayton E, Pertuiset E, et al
    Right hip and bilateral shoulder capsulitis in an HIV-infected individual treated with elvitegravir and cobicistat.
    AIDS. 2017;31:1195-1196.
    PubMed     Text format    


  207. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in MSM.
    AIDS. 2017;31:1169-1180.
    PubMed     Text format     Abstract available


  208. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    Acceptability and use of a dapivirine vaginal ring in a phase III trial.
    AIDS. 2017;31:1159-1167.
    PubMed     Text format     Abstract available


  209. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    AIDS. 2017;31:1099-1107.
    PubMed     Text format     Abstract available


  210. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-CMV drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001532.
    PubMed     Text format     Abstract available


  211. TOBIN SC
    WHO provides additional guidance on HIV self-testing and partner notification.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001537.
    PubMed     Text format    


  212. MORENO M, Caballero E, Mateus RM, Samba F, et al
    HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001536.
    PubMed     Text format    


  213. CABY F
    CD4/CD8 ratio restoration in long-term treated HIV-1-infected individuals: Incidence and determinants.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001533.
    PubMed     Text format     Abstract available


  214. KENNEDY CE, Yeh PT, Pandey S, Betran AP, et al
    Elective cesarean section for women living with HIV: a systematic review of risks and benefits.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001535.
    PubMed     Text format     Abstract available


  215. SHANAUBE K, Schaap A, Floyd S, Phiri M, et al
    What works-reaching universal hiv testing: lessons from HPTN 071 (PopART) trial in Zambia.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001514.
    PubMed     Text format     Abstract available


  216. COBAN H, Robertson K, Smurzynski M, Krishnan S, et al
    Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV+ individuals on their first suppressive regimen.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001523.
    PubMed     Text format     Abstract available


  217. CREPAZ N, Dong B, Chen M, Hall I, et al
    Examination of HIV infection through heterosexual contact with partners who are known to be HIV infected in the United States, 2010-2015.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001526.
    PubMed     Text format     Abstract available


  218. GUNST JD, Tolstrup M, Sogaard OS
    Beyond antiretroviral therapy: Early interventions to control HIV-1 infection.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001524.
    PubMed     Text format    


  219. KIM CJ, Rousseau R, Huibner S, Kovacs C, et al
    Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers: a randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001515.
    PubMed     Text format     Abstract available


  220. TRIPLETTE M, Sigel KM, Morris A, Shahrir S, et al
    Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: Implications for lung cancer screening.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001529.
    PubMed     Text format     Abstract available


  221. LAL L, Audsley J, Murphy D, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001519.
    PubMed     Text format     Abstract available


  222. LONG LC, Maskew M, Brennan AT, Mongwenyana C, et al
    Initiating antiretroviral therapy for HIV at a patient's first clinic visit: A cost-effectiveness analysis of the RapIT randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001528.
    PubMed     Text format     Abstract available


  223. HOORNENBORG E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, et al
    Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001522.
    PubMed     Text format     Abstract available


  224. ONOYA D, Sineke T, Brennan A, Long L, et al
    Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001517.
    PubMed     Text format     Abstract available


  225. ANDERSON DJ, Politch JA, Zeitlin L, Hiatt A, et al
    Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001521.
    PubMed     Text format     Abstract available


    April 2017
  226. WINSTON A, Julie F, Fidler S
    HIV cure strategies: response to ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:1051-1052.
    PubMed     Text format    


  227. LE GARFF G, Samri A, Lambert-Niclot S, Even S, et al
    Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
    AIDS. 2017;31:1048-1051.
    PubMed     Text format    


  228. MCLEAN FE, Gathogo E, Goodall D, Jones R, et al
    Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
    AIDS. 2017;31:1047-1048.
    PubMed     Text format    


  229. FRANCESCHI S, Clifford GM
    Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status.
    AIDS. 2017;31:1045-1046.
    PubMed     Text format    


  230. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
    AIDS. 2017;31:1025-1034.
    PubMed     Text format     Abstract available


  231. BREGIGEON S, Galinier A, Zaegel-Faucher O, Cano CE, et al
    Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001507.
    PubMed     Text format     Abstract available


  232. SCHAEFER R, Gregson S, Eaton JW, Mugurungi O, et al
    Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from a general-population cohort in Zimbabwe.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001506.
    PubMed     Text format     Abstract available


  233. GIBELLINI L, Pecorini S, de Biasi S, Bianchini E, et al
    HIV-DNA content in different CD4+ T cell subsets correlates with CD4: CD8 ratio or length of efficient treatment.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001510.
    PubMed     Text format     Abstract available


  234. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511.
    PubMed     Text format     Abstract available


  235. MAURICE JB, Patel A, Scott AJ, Patel K, et al
    Prevalence and risk factors of non-alcoholic fatty liver disease in HIV-monoinfection: a systematic review and meta-analysis.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001504.
    PubMed     Text format     Abstract available


  236. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    PubMed     Text format     Abstract available


  237. PUTCHAROEN O, Wattanachanya L, Sophonphan J, Siwamogsatham S, et al
    New-onset diabetes in hiv treated adults from thailand: predictors, long-term renal and cardiovascular outcomes.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001496.
    PubMed     Text format     Abstract available


  238. SWEENEY P, Gray SC, Purcell DW, Sewell J, et al
    Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001501.
    PubMed     Text format     Abstract available


  239. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001503.
    PubMed     Text format     Abstract available


  240. MCGRATH N, Grapsa E
    Does ART change partnership dynamics and HIV risk behaviours among PLWH? A cohort study in KwaZulu-Natal, South Africa.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001502.
    PubMed     Text format     Abstract available


  241. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving towards test and start: learning from the experience of universal ART programs for HIV-infected pregnant/breastfeeding women.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001498.
    PubMed     Text format     Abstract available


  242. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    PubMed     Text format     Abstract available


  243. VAN BILSEN WP, van den Berg CH, Rijnders BJ, Brinkman K, et al
    Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in hiv-infected patients: a multicenter cohort study.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001492.
    PubMed     Text format     Abstract available


  244. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS).
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001493.
    PubMed     Text format     Abstract available


  245. MAHY M, Penazzato M, Ciaranello A, Mofenson L, et al
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS. 2017;31 Suppl 1:S13-S22.
    PubMed     Text format     Abstract available


  246. WILSON KC, Mhangara M, Dzangare J, Eaton JW, et al
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS. 2017;31 Suppl 1:S95-S102.
    PubMed     Text format     Abstract available


  247. SHENG B, Marsh K, Slavkovic AB, Gregson S, et al
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS. 2017;31 Suppl 1:S87-S94.
    PubMed     Text format     Abstract available


  248. MASQUELIER B, Eaton JW, Gerland P, Pelletier F, et al
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS. 2017;31 Suppl 1:S77-S85.
    PubMed     Text format     Abstract available


  249. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS. 2017;31 Suppl 1:S69-S76.
    PubMed     Text format     Abstract available


  250. EATON JW, Bao L
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS. 2017;31 Suppl 1:S61-S68.
    PubMed     Text format     Abstract available


  251. NIU X, Zhang A, Brown T, Puckett R, et al
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS. 2017;31 Suppl 1:S51-S59.
    PubMed     Text format     Abstract available


  252. SILHOL R, Gregson S, Nyamukapa C, Mhangara M, et al
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS. 2017;31 Suppl 1:S41-S50.
    PubMed     Text format     Abstract available


  253. ANDEREGG N, Johnson LF, Zaniewski E, Althoff KN, et al
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS. 2017;31 Suppl 1:S31-S40.
    PubMed     Text format     Abstract available


  254. MAHIANE SG, Marsh K, Grantham K, Crichlow S, et al
    Improvements in Spectrum's fit to program data tool.
    AIDS. 2017;31 Suppl 1:S23-S30.
    PubMed     Text format     Abstract available


  255. STOVER J, Brown T, Puckett R, Peerapatanapokin W, et al
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS. 2017;31 Suppl 1:S5-S11.
    PubMed     Text format     Abstract available


  256. CASE KK, Gregson S, Mahy M, Ghys PD, et al
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS. 2017;31 Suppl 1:S1-S4.
    PubMed     Text format    


    March 2017
  257. MONTES ML, Olveira A, Ahumada A, Aldamiz T, et al
    Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001465.
    PubMed     Text format     Abstract available


  258. VALVERDE-VILLEGAS JM, Medeiros RM, Andrade KP, Jacovas VC, et al
    Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001491.
    PubMed     Text format     Abstract available


  259. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001487.
    PubMed     Text format     Abstract available


  260. EKINS S, Mathews P, Saito EK, Diaz N, et al
    alpha-7-nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001488.
    PubMed     Text format     Abstract available


  261. BELLAVIA A, Williams PL, Dimeglio LA, Hazra R, et al
    Delay in sexual maturation in perinatally HIV-infected youth is mediated by poor growth.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001486.
    PubMed     Text format     Abstract available


  262. DE MENDOZA C, Cabezas T, Caballero E, Requena S, et al
    HIV-2 Epidemic in Spain - Challenges and Missing Opportunities.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001485.
    PubMed     Text format     Abstract available


  263. EL-DIWANY R, Breitwieser FP, Soliman M, Skaist AM, et al
    Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001480.
    PubMed     Text format     Abstract available


  264. YU C, Seaton M, Letendre S, Heaton R, et al
    Plasma Dickkopf-related Protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001481.
    PubMed     Text format     Abstract available


  265. RAJASURIAR R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, et al
    Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001475.
    PubMed     Text format     Abstract available


  266. STEKLER JD, Ure G, Dragavon J, Chang M, et al
    Detection of HIV RNA in dried blood spots and oral fluids.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001477.
    PubMed     Text format     Abstract available


  267. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in TB/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001471.
    PubMed     Text format    


  268. IANTORNO M, Schar M, Soleimanifard S, Brown TT, et al
    Coronary artery endothelial dysfunction is present in HIV positive individuals without significant coronary artery disease.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001469.
    PubMed     Text format     Abstract available


  269. MARSHALL BD, Tate JP, Mcginnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001473.
    PubMed     Text format     Abstract available


  270. HASSAN AS, Pybus OG, Sanders EJ, Albert J, et al
    Defining HIV-1 transmission clusters based on sequence data: a systematic review and perspectives.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001470.
    PubMed     Text format     Abstract available


  271. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001464.
    PubMed     Text format     Abstract available


  272. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision (VMMC) uptake among adult men in Tanzania: A randomised controlled trial.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001440.
    PubMed     Text format     Abstract available


  273. MAHALINGASIVAM V, Gathogo E, Bramham K, Post FA, et al
    Successful pregnancy in an HIV-positive kidney transplant recipient.
    AIDS. 2017;31:872-873.
    PubMed     Text format    


  274. JINDAL AK, Ahluwalia J, Sharma A, Dhawan S, et al
    HIV-infected children with hepatomegaly and ascites: is there something more than an infection?
    AIDS. 2017;31:870-872.
    PubMed     Text format    


  275. GOEDERT JJ
    The microbiota and HIV: shedding light on dark matters.
    AIDS. 2017;31:863-865.
    PubMed     Text format    



  276. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    AIDS. 2017;31:835-846.
    PubMed     Text format     Abstract available


  277. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.
    AIDS. 2017;31:827-833.
    PubMed     Text format     Abstract available


  278. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
    AIDS. 2017;31:771-779.
    PubMed     Text format     Abstract available


  279. OZANNE A, Duffau P, Dauchy FA, Rigothier C, et al
    Activation, senescence and inflammation markers in HIV patients: association with renal function.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001461.
    PubMed     Text format     Abstract available


  280. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001448.
    PubMed     Text format     Abstract available


  281. PRICE H, Dunn D, Zachary T, Vudriko T, et al
    Hepatitis B serological markers and plasma DNA concentrations: baseline results from the DART trial.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001454.
    PubMed     Text format     Abstract available


  282. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001455.
    PubMed     Text format     Abstract available


  283. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Text format     Abstract available


  284. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Text format     Abstract available


  285. SAMUELS R, Bayerri CR, Sayer JA, Price DA, et al
    TDF associated renal tubular dysfunction: non-invasive assessment of mitochondrial injury.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001466.
    PubMed     Text format     Abstract available


  286. MOORE CB, Capparelli EV, Samson P, Bwakura-Dangarembizi M, et al
    CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001463.
    PubMed     Text format     Abstract available


  287. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    "It's inside my body and it's mine".
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452.
    PubMed     Text format     Abstract available


  288. MUKANDAVIRE C, Low A, Mburu G, Trickey A, et al
    Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001458.
    PubMed     Text format     Abstract available


  289. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001451.
    PubMed     Text format     Abstract available


  290. GAGNEUX-BRUNON A, Rochereau N, Botelho-Nevers E, Lucht F, et al
    Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001460.
    PubMed     Text format     Abstract available


  291. MCALLISTER J, Towns JM, Mcnulty A, Pierce AB, et al
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447.
    PubMed     Text format     Abstract available


  292. MANGAL TD
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437.
    PubMed     Text format     Abstract available


  293. MOTA TM, Rasmussen TA, Rhodes A, Tennakoon S, et al
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001442.
    PubMed     Text format     Abstract available


  294. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    PubMed     Text format     Abstract available


  295. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    PubMed     Text format     Abstract available


  296. KONG X, Kigozi G, Ssekasanvu J, Nalugoda F, et al
    Medical male circumcision coverage in Rakai, Uganda.
    AIDS. 2017;31:735-737.
    PubMed     Text format     Abstract available


  297. CZAICKI NL, Holmes CB, Sikazwe I, Bolton C, et al
    Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics.
    AIDS. 2017;31:689-696.
    PubMed     Text format     Abstract available


  298. HARAWA NT, Holloway IW, Leibowitz A, Weiss R, et al
    Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition.
    AIDS. 2017;31:739-740.
    PubMed     Text format    


  299. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretroviral medication.
    AIDS. 2017;31:719-726.
    PubMed     Text format     Abstract available


  300. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    AIDS. 2017;31:613-622.
    PubMed     Text format     Abstract available


  301. TOBIN SC
    Evaluating the generalizability of clinical trials of direct-acting antivirals for HIV/HCV-coinfection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001439.
    PubMed     Text format    


  302. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Text format     Abstract available


  303. MARCUS JL, Leyden WA, Chao CR, Horberg MA, et al
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001434.
    PubMed     Text format     Abstract available


  304. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    PubMed     Text format     Abstract available


  305. KIRKEGAARD-KLITBO DM, Mejer N, Knudsen TB, Moller HJ, et al
    Soluble CD163 Predicts Incident Chronic Lung, Kidney and Liver Disease in HIV Infection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001432.
    PubMed     Text format     Abstract available


  306. MAHEU-GIROUX M, Tanser F, Boily MC, Pillay D, et al
    Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001435.
    PubMed     Text format     Abstract available


    February 2017
  307. BENGTSON AM, Pence BW, Moore R, Mimiaga MJ, et al
    The relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001431.
    PubMed     Text format     Abstract available


  308. BRYANT AK, Moore DJ, Burdo TH, Lakritz JR, et al
    Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001425.
    PubMed     Text format     Abstract available


  309. VESA J, Chaillon A, Wagner GA, Anderson CM, et al
    Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001445.
    PubMed     Text format     Abstract available



  310. First evidence of intra-familial transmission of an HIV-1 M/O intergroup recombinant virus: Erratum.
    AIDS. 2017;31:601.
    PubMed     Text format    


  311. KASIRYE RP, Grosskurth H, Munderi P, Levin J, et al
    Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.
    AIDS. 2017;31:577-582.
    PubMed     Text format     Abstract available


  312. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    PubMed     Text format     Abstract available


  313. TAKUVA S, Brown AE, Pillay Y, Delpech V, et al
    The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.
    AIDS. 2017;31:545-552.
    PubMed     Text format     Abstract available


  314. JOSE S, Nelson M, Phillips A, Chadwick D, et al
    Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.
    AIDS. 2017;31:485-492.
    PubMed     Text format     Abstract available


  315. MANDAL S, Prathipati PK, Kang G, Zhou Y, et al
    Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
    AIDS. 2017;31:469-476.
    PubMed     Text format     Abstract available


  316. RAFIEI N, Woolley I, Korman TM, Chibo D, et al
    Integrase-resistant HIV in an antiretroviral-naive patient in Australia.
    AIDS. 2017;31:598-600.
    PubMed     Text format    


  317. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
    AIDS. 2017;31:596-598.
    PubMed     Text format    


  318. WEN Y, Li JZ
    Post-treatment HIV controllers or spontaneous controllers in disguise?
    AIDS. 2017;31:587-589.
    PubMed     Text format    


    January 2017
  319. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy.
    AIDS. 2017;31:451-453.
    PubMed     Text format     Abstract available


  320. SCHUSTER C, Binder C, Strassl R, Aichelburg MC, et al
    Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.
    AIDS. 2017;31:395-400.
    PubMed     Text format     Abstract available


  321. REID M, Ma Y, Scherzer R, Price JC, et al
    Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
    AIDS. 2017;31:385-393.
    PubMed     Text format     Abstract available



  322. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


  323. AKUA T, Rahav G, Saragani Y, Hizi A, et al
    Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase.
    AIDS. 2017;31:343-353.
    PubMed     Text format     Abstract available


  324. BORGHETTI A, Baldin G, Capetti A, Sterrantino G, et al
    Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
    AIDS. 2017;31:457-459.
    PubMed     Text format    


  325. AHMAD A, Rinaldo CR
    A novel anti-HIV immunotherapy to cure HIV.
    AIDS. 2017;31:447-449.
    PubMed     Text format    


  326. SORIANO V, Sherman KE, Barreiro P
    Hepatitis Delta and HIV Infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001424.
    PubMed     Text format     Abstract available


  327. SU S, Wang Q, Xu W, Yu F, et al
    A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001415.
    PubMed     Text format     Abstract available


  328. PATEL EU, Gianella S, Newell K, Tobian AA, et al
    Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001412.
    PubMed     Text format     Abstract available


  329. PINATO DJ, Pria AD, Sharma R, Bower M, et al
    Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001422.
    PubMed     Text format     Abstract available


  330. LIFSON AR, Grund B, Gardner EM, Kaplan R, et al
    Improved quality of life with immediate initiation of antiretroviral therapy in the strategic timing of antiretroviral therapy trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001417.
    PubMed     Text format     Abstract available


  331. CHEHOUD C, Stieh DJ, Bailey AG, Laughlin AL, et al
    Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001421.
    PubMed     Text format     Abstract available


  332. SU T, Mutsaerts HJ, Caan MW, Wit FW, et al
    Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001414.
    PubMed     Text format     Abstract available


  333. CROOME N, Ahluwalia M, Hughes LD, Abas M, et al
    Patient-reported barriers and facilitators to antiretroviral adherence in Sub-Saharan Africa: a systematic review.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001416.
    PubMed     Text format     Abstract available


  334. JOSHI PH, Miller PE, Martin SS, Jones SR, et al
    Greater remnant lipoprotein cholesterol reduction with pitavastatin compared to pravastatin in HIV-infected patients: The INTREPID trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001423.
    PubMed     Text format     Abstract available


  335. NOWAK RG, Bentzen SM, Ravel J, Crowell TA, et al
    Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected men who have sex with men (MSM) in Nigeria.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001409.
    PubMed     Text format     Abstract available


  336. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408.
    PubMed     Text format     Abstract available



  337. Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013).
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001411.
    PubMed     Text format     Abstract available


  338. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001400.
    PubMed     Text format     Abstract available


  339. MCCOY SI, Njau PF, Fahey C, Kapologwe N, et al
    Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania: a randomized trial.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001406.
    PubMed     Text format     Abstract available


  340. KRAFT JC, McConnachie LA, Koehn J, Kinman L, et al
    Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001405.
    PubMed     Text format     Abstract available


  341. MONTOYA JL, Iudicello J, Oppenheim HA, Fazeli PL, et al
    Coagulation imbalance and neurocognitive functioning in older HIV+ adults on suppressive antiretroviral therapy.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001404.
    PubMed     Text format     Abstract available


  342. BALINANG JM, Masvekar RR, Hauser KF, Knapp PE, et al
    Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001398.
    PubMed     Text format     Abstract available


  343. SEREMBA E, Ssempijja V, Kalibbala S, Gray RH, et al
    Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001399.
    PubMed     Text format     Abstract available


  344. BAI F, Iannuzzi F, Merlini E, Borghi L, et al
    Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naive HIV-infected patients.
    AIDS. 2017;31:311-314.
    PubMed     Text format     Abstract available


  345. HOST KM, Horner MJ, van der Gronde T, Moses A, et al
    Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:318-319.
    PubMed     Text format    


  346. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al.
    AIDS. 2017;31:317.
    PubMed     Text format    


  347. POWIS KM, Slogrove AL, Mofenson L
    Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.
    AIDS. 2017;31:315-316.
    PubMed     Text format    


  348. CACERES CF
    Educational attainment and intersectionality in the response to HIV antiretroviral treatment in Europe.
    AIDS. 2017;31:305-307.
    PubMed     Text format    


  349. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV.
    AIDS. 2017;31:295-304.
    PubMed     Text format     Abstract available


  350. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    PubMed     Text format     Abstract available


  351. CALZA L, Magistrelli E, Colangeli V, Borderi M, et al
    Significant association between statin-associated myalgia and vitamin d deficiency among treated hiv-infected patients.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001397.
    PubMed     Text format     Abstract available


  352. NUNN AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, et al
    Defining the HIV Pre-Exposure Prophylaxis Care Continuum.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001385.
    PubMed     Text format    


  353. SABIN CA, Howarth A, Jose S, Hill T, et al
    Association between engagement in-care and mortality in HIV-positive persons: a cohort study.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001373.
    PubMed     Text format     Abstract available


  354. WEINBERG A, Mussi-Pinhata MM, Yu Q, Cohen RA, et al
    Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001393.
    PubMed     Text format     Abstract available


  355. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments NK-mediated antibody-dependent cellular cytotoxicity (ADCC) of HIV-1 infected autologous CD4+ T cells regardless of MHC-I downregulation.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001380.
    PubMed     Text format     Abstract available


  356. FERREIRA MP, Coghill AE, Chaves CB, Bergmann A, et al
    Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013).
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001367.
    PubMed     Text format     Abstract available


  357. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretrovirals: early evidence from a randomized controlled trial in Uganda.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001387.
    PubMed     Text format     Abstract available


  358. MARTIN GE, Gossez M, Williams JP, Stohr W, et al
    Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001382.
    PubMed     Text format     Abstract available


  359. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    PubMed     Text format     Abstract available


  360. TINAGO W, Cotter AG, Sabin C, Macken A, et al
    Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative subjects.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001372.
    PubMed     Text format     Abstract available


  361. ANGIN M, Fathi A, King M, Ledoux MB, et al
    Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001390.
    PubMed     Text format     Abstract available


  362. STREECK H, Verheyen J, Storim J, Dittmer U, et al
    Pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:176-177.
    PubMed     Text format    


  363. SPECTOR SA, Rappaport J
    HIV cure strategists: ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:167-168.
    PubMed     Text format    



  364. Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.
    AIDS. 2017;31:127-135.
    PubMed     Text format     Abstract available


  365. NEWSUM AM, Ho CK, Lieveld FI, van de Laar TJ, et al
    The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2017;31:105-112.
    PubMed     Text format     Abstract available


  366. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    AIDS. 2017;31:97-104.
    PubMed     Text format     Abstract available


  367. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques.
    AIDS. 2017;31:5-14.
    PubMed     Text format     Abstract available


  368. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2017;31:147-157.
    PubMed     Text format     Abstract available


    December 2016
  369. VENKATACHARI NJ, Jain S, Walker L, Bivalkar-Mehla S, et al
    Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001379.
    PubMed     Text format     Abstract available


  370. PETERS L, Cozzi-Lepri A
    Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001378.
    PubMed     Text format     Abstract available


  371. BRENNER BG, Ibanescu RI, Hardy I, Stephens D, et al
    Large cluster outbreaks sustain the HIV epidemic among men having sex with men (MSM) in Quebec from 2002 to 2015.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001383.
    PubMed     Text format     Abstract available


  372. HARPER KN
    New mouse models provide insights into how to design a more effective HIV vaccine.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001371.
    PubMed     Text format    


  373. HARPER KN
    Do HIV-infected children who do not develop AIDS hold clues to a cure?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001370.
    PubMed     Text format    


  374. HARPER KN
    To break patent or not to break patent: What is in the best interests of HIV patients in low-income countries?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001369.
    PubMed     Text format    


  375. DILLON SM, Kibbie J, Lee EJ, Guo K, et al
    Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001366.
    PubMed     Text format     Abstract available


  376. KROIDL A, Ello F, Mgaya J, Lennemann T, et al
    Virological efficacy of 24-weeks fozivudine based regimen in ART-naive patients from tanzania and cote d'Ivoire.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  377. MORRIS A, Fitzpatrick M, Bertolet M, Qin S, et al
    Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease: A randomized pilot study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  378. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  379. DIRAJLAL-FARGO S, Alam SM, Sattar A, Kulkarni M, et al
    Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  380. LUNSKY Y, Durbin A, Brown HK, Bansal S, et al
    Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  381. MERCHANTE N, Rivero-Juarez A, Tellez F, Merino D, et al
    Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  382. NELSON KN, Hui Q, Rimland D, Xu K, et al
    Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naive U.S. veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2016
  383. WESTREICH D, Cates J, Cohen M, Weber KM, et al
    Smoking, HIV, and risk of pregnancy loss.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  384. PAZ-BAILEY G, Wejnert C, Mendoza MC, Prejean J, et al
    Response to diversification of risk-reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2900-2901.
    PubMed     Text format    


  385. KIPPAX S, Holt M
    Diversification of risk reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2898-2899.
    PubMed     Text format    


  386. AUTRAN B, Pogliaghi M, Katlama C
    Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2896-2898.
    PubMed     Text format    


  387. PALMER CS, Crowe SM
    Immunometabolism may provide new insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2895-2896.
    PubMed     Text format    


  388. DARCIS G, Coombs RW, Van Lint C
    Exploring the anatomical HIV reservoirs: role of the testicular tissue.
    AIDS. 2016;30:2891-2893.
    PubMed     Text format    


  389. VASYLYEVA TI, Friedman SR, Lourenco J, Gupta S, et al
    Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    AIDS. 2016;30:2885-2890.
    PubMed     Text format     Abstract available


  390. DE BOER MG, van den Berk GE, van Holten N, Oryszcyn JE, et al
    Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.
    AIDS. 2016;30:2831-2834.
    PubMed     Text format     Abstract available


  391. TORT O, Sanchez-Palomino S, Escriba T, Calvo C, et al
    omega-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?
    AIDS. 2016;30:2733-2735.
    PubMed     Text format    


  392. BRENNER B, Wainberg MA
    We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    AIDS. 2016;30:2725-2727.
    PubMed     Text format    


  393. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


  394. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
    AIDS. 2016;30:2685-2695.
    PubMed     Text format     Abstract available


  395. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    AIDS. 2016;30:2659-2663.
    PubMed     Text format     Abstract available


  396. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
    AIDS. 2016;30:2599-2610.
    PubMed     Text format     Abstract available


  397. VANCE DE
    Interpreting the influence of race and cognitive activity on neurocognition in adults aging with HIV.
    AIDS. 2016.
    PubMed     Text format    


  398. YOUNAS M, Carrat F, Finge S, Desaint C, et al
    Immune activation, smoking, and vaccine response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  399. VIGANO S, Negron JJ, Tse S, Chowdhury FZ, et al
    HLA-G+ HIV-1-specific CD8 T cells are associated with HIV-1 immune control.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  400. BUTTERFIELD TR, Hanna DB, Kaplan RC, Kizer JR, et al
    Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  401. GOSSELIN A, Wiche Salinas TR, Planas D, Wacleche VS, et al
    HIV persists in CCR6+CD4+ T-cells from colon and blood during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  402. KRUEGER KR, Adeyemi O, Leurgans S, Shah RC, et al
    Association of cognitive activity and neurocognitive function in blacks and whites with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  403. SELVA KJ, Kent SJ, Parsons MS
    Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  404. SUDFELD CR, Kaaya S, Gunaratna NS, Mugusi F, et al
    Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  405. SHIAU S, Strehlau R, Technau KG, Patel F, et al
    Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  406. GUELER A, Moser A, Calmy A, Gunthard HF, et al
    Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  407. MOFENSON LM, Baggaley RC, Mameletzis I
    Tenofovir Disoproxil Fumarate Safety for Women and their Infants during Pregnancy and Breastfeeding: Systematic Review.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  408. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  409. GREEN N, Hoenigl M, Chaillon A, Anderson CM, et al
    Partner services in adults with acute and early HIV infection, San Diego, 1996-2014.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  410. KARDASHIAN A, Ma Y, Scherzer R, Price JC, et al
    Sex differences in the association of HIV infection with hepatic steatosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  411. BRAND D, Capsec J, Chaillon A, Cazein F, et al
    HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  412. NAKAGAWA F, Phillips A
    An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings: an application in the UK.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  413. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV: trends and disparities from 1996 to 2013.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  414. CHRISTOPOULOS K, Hartogensis W, Glidden DV, Pilcher CD, et al
    The lorenz curve: a novel method for understanding viral load distribution at the population level.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  415. PELUSO MJ, Valcour V, Phanuphak N, Ananworanich J, et al
    Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    October 2016
  416. MIRKOVIC KR, Rivadeneira ED, Broyles LN
    Children and alternative service delivery models: a case for inclusion.
    AIDS. 2016;30:2569-2570.
    PubMed     Text format    


  417. UNAL G, Mourez T, Leoz M, Alessandri-Gradt E, et al
    First report of transmission of a highly resistant strain of HIV-1 group O.
    AIDS. 2016;30:2565-2568.
    PubMed     Text format    


  418. ZOLLA-PAZNER S
    Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.
    AIDS. 2016;30:2551-2553.
    PubMed     Text format    


  419. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    AIDS. 2016;30:2495-2504.
    PubMed     Text format     Abstract available


  420. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2016;30:2469-2476.
    PubMed     Text format     Abstract available


  421. FRIEDMAN EE, Duffus WA
    Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016;30:2529-2536.
    PubMed     Text format     Abstract available


  422. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before ART availability: Fertility by duration of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  423. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  424. SPRENGER HG, Bierman WF, Martes MI, Graaff R, et al
    Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  425. HARPER KN
    New research on using CRISPR/Cas9 to treat HIV.
    AIDS. 2016.
    PubMed     Text format    


  426. GIANELLA S, Taylor J, Brown TR, Kaytes A, et al
    Can research at the end-of-life be a useful tool to advance HIV cure?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  427. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  428. CHOPERA DR, Ntale R, Ndabambi N, Garrett N, et al
    Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  429. MERCHANTE N, Ibarra S, Revollo B, Rodriguez-Arrondo F, et al
    Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients (RIS-HEP12/GEHEP-002 study).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  430. TAKEMOTO JK, Miller TL, Wang J, Jacobson DL, et al
    Insulin Resistance in HIV-Infected Youth is associated with decreased mitochondrial respiration.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  431. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  432. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  433. DARCIS G, Bouchat S, Kula A, Van Driessche B, et al
    Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  434. AHRENSTORF G, Low HZ, Kniesch K, Ordonez D, et al
    LILRA3 deletion is a genetic risk factor of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  435. HARPER KN
    The 2nd Durban Declaration draws attention to progress in the fight against HIV and work yet to do.
    AIDS. 2016.
    PubMed     Text format    


  436. HARPER KN
    HIV-altered gut microbiome may be driving disease progression.
    AIDS. 2016.
    PubMed     Text format    


  437. DILLON SM, Frank DN, Wilson CC
    The gut microbiome and HIV-1 pathogenesis: a two way street.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  438. DOBRA A, Barnighausen T, Vandormael A, Tanser F, et al
    Space-time migration patterns and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    September 2016
  439. GUPTA SK, Kamendulis LM, Clauss MA, Liu Z, et al
    A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
    AIDS. 2016;30:2389-91.
    PubMed     Text format    


  440. LUZURIAGA K, Persaud D
    Treatment interruption after early-treated perinatal HIV-1 infection.
    AIDS. 2016;30:2381-3.
    PubMed     Text format    


  441. BREW BJ
    Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
    AIDS. 2016;30:2379-80.
    PubMed     Text format    


  442. DE BOER M, van den Berk G, van Holten N, Oryszczyn J, et al
    Intolerance of dolutegravir containing cART regimens in real life clinical practice.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  443. TAO J, Qian HZ, Kipp AM, Ruan Y, et al
    Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed hiv-infected chinese men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  444. BEDOYA LM, Beltran M, Obregon-Calderon P, Garcia-Perez J, et al
    Hydroxytyrosol. a new class of microbicide displaying broad anti HIV-1 activity.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  445. SCHERZER R, Heymsfield SB, Rimland D, Powderly WG, et al
    Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  446. SOEPNEL LM, Norris SA, Schrier VJ, Browne JL, et al
    The association between HIV, antiretroviral therapy and gestational diabetes mellitus: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  447. THORNE C, Turkova A, Indolfi G, Venturini E, et al
    Co-infection with HIV and HCV in 229 children and young adults living in Europe.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  448. MURI L, Gamell A, Ntamatungiro AJ, Glass TR, et al
    Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  449. JENABIAN MA, Costiniuk CT, Mehraj V, Ghazawi FM, et al
    Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  450. MUKHERJEE PK, Chen H, Patton LL, Evans S, et al
    Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 Infected participants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  451. GUARDO AC, Joe PT, Miralles L, Bargallo ME, et al
    Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  452. TELWATTE S, Brumme CJ, Hearps AC, Latham CF, et al
    Increasing Prevalence of Synonymous Mutations K65K and K66K in HIV-1 subtype B reverse transcriptase.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  453. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  454. DEL AMO J
    Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe (1996-2013): a collaborative cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  455. PRENDERGAST AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, et al
    Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  456. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of SIV reservoirs in the brain of virally suppressed macaques.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  457. ALAEI K, Paynter CA, Juan SC, Alaei A, et al
    Using PrEP, losing condoms? PrEP promotion may undermine safe sex.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  458. NEWSUM AM, Ho CK, Lieveld FI, Van De Laar TJ, et al
    The hepatitis C virus NS3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  459. LEVIN MJ, Lindsey JC, Kaplan SS, Schimana W, et al
    Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  460. PINES HA, Wertheim JO, Liu L, Garfein RS, et al
    Concurrency and HIV transmission network characteristics among men who have sex with men with recent HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  461. GAY CL, Willis SJ, Cope AB, Kuruc JD, et al
    Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  462. HLEYHEL M, Goujon S, Sibiude J, Blanche S, et al
    In utero exposure to NELFINAVIR-EMS.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  463. KUZNIK A, Iliyasu G, Habib AG, Musa BM, et al
    Initiation of antiretroviral therapy based on the 2015 WHO guidelines: A cost-effectiveness analysis in Nigeria, South Africa, Uganda and India.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  464. RYLANCE J, Mchugh G, Metcalfe J, Mujuru H, et al
    Chronic lung disease in HIV-infected children established on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  465. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term body composition changes in antiretroviral-treated HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  466. SCHNEIDER JA, Kozloski M, Michaels S, Skaathun B, et al
    Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  467. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption: Erratum.
    AIDS. 2016;30:2259.
    PubMed     Text format    


  468. VASSALLO M, De Monte A, Durant J, Dunais B, et al
    Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
    AIDS. 2016;30:2257-8.
    PubMed     Text format    


  469. CAMASMIE HR, Leda SB, Lupi O, Lima RB, et al
    Chronic herpetic whitlow as the first manifestation of HIV infection.
    AIDS. 2016;30:2254-6.
    PubMed     Text format    


  470. CUERVO G, Simonetti AF, Alegre O, Sanchez-Salado JC, et al
    Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter.
    AIDS. 2016;30:2253-4.
    PubMed     Text format    


  471. RAJA SK, Aggarwal S, Raman KR, Minteer WB, et al
    From businesswoman to banana vendor: mental health implications of HIV stigma in Tanzania.
    AIDS. 2016.
    PubMed     Text format    


  472. SCHRACK JA, Jacobson LP, Althoff KN, Erlandson KM, et al
    Effect of HIV-infection and cumulative viral load on age-related decline in grip strength.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  473. ASBJORNSDOTTIR KH, Hughes JP, Wamalwa D, Langat A, et al
    Differences in virologic and immunologic response to antiretroviral therapy among HIV-1 infected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  474. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  475. TJIAM MC, Sariputra L, Armitage JD, Taylor JP, et al
    Control of early HIV-1 infection associates with plasmacytoid DC-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  476. BROWN LB, Havlir DV, Ayieko J, Mwangwa F, et al
    High levels of retention in care with streamlined care and universal test-and-treat in East Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  477. VUILLE-LESSARD E, Lebouche B, Lennox L, Routy JP, et al
    nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV mono-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  478. KELESIDIS T, Jackson N, McComsey GA, Wang X, et al
    Oxidized lipoproteins are associated with markers of inflammation andimmune activation in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  479. VILLABONA-ARENAS CJ, Vidal N, Guichet E, Serrano L, et al
    In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  480. GUPTA SK, Dube MP, Stein JH, Clauss MA, et al
    A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2016;30:2139-42.
    PubMed     Text format    


  481. MILLARD JD, Henry J, Rizvi SS, Nelson M, et al
    Direct-acting antivirals for acute hepatitis C in HIV-infected MSM.
    AIDS. 2016;30:2137-9.
    PubMed     Text format    


  482. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
    AIDS. 2016;30:2135-7.
    PubMed     Text format    


  483. BRADLEY H, Mattson CL, Beer L, Huang P, et al
    Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.
    AIDS. 2016;30:2117-24.
    PubMed     Text format     Abstract available


  484. MULANOVICH VE, Desai PA, Popat UR
    Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies: report of 5 cases after 2010.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  485. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  486. WAGNER GA, Chaillon A, Liu S, Franklin DR Jr, et al
    HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  487. SMITH JA, Daniel R
    Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  488. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  489. MOSEHOLM E, Helleberg M, Nordly SB, Rosenfeldt V, et al
    Hospital admission among HIV-exposed uninfected children compared to HIV-unexposed children - a nationwide cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  490. TCHOUNGA BK, Hnge BL, Eholie SP, Coffie PA, et al
    Effect of sex and age on outcomes among hiv-2 infected patients starting antiretroviral therapy in west africa: a multicentre cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  491. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


  492. BUGGERT M, Frederiksen J, Lund O, Betts MR, et al
    CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  493. EMMER KL, Wieczorek L, Tuyishime S, Molnar S, et al
    Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  494. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and art use in the kenya AIDS indicator survey 2012: relevance to targets for HIV diagnosis and treatment in kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  495. POLIS CB, Phillips SJ, Hillier SL, Achilles SL, et al
    Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?
    AIDS. 2016.
    PubMed     Text format    


  496. POLIS CB, Curtis KM, Hannaford PC, Phillips SJ, et al
    Update on hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, 2016.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  497. GILL AL, Green SA, Abdullah S, Le Saout C, et al
    PD1/PD-L1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-PD-L1 (Avelumab).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  498. ESCUDERO DJ, Lurie MN, Mayer KH, Weinreb C, et al
    Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  499. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  500. THOMAS GP, Li X, Post WS, Jacobson LP, et al
    Associations between antiretroviral use and subclinical coronary atherosclerosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  501. GOWDA C, Brown TT, Compher C, Forde KA, et al
    Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  502. KRUBINER CB, Faden RR, Cadigan RJ, Gilbert SZ, et al
    Advancing HIV research with pregnant women: navigating challenges and opportunities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    July 2016

  503. Long-term impact of HIV wasting on physical function: Erratum.
    AIDS. 2016;30:2007.
    PubMed     Text format    



  504. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection: Erratum.
    AIDS. 2016;30:2005.
    PubMed     Text format    


  505. CACHAY E, Soriano V
    Is HIV still a special population for the treatment of hepatitis C?
    AIDS. 2016;30:2001-3.
    PubMed     Text format    


  506. SCHALKWIJK S, Feiterna-Sperling C, Weizsacker K, Colbers A, et al
    Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant woman.
    AIDS. 2016;30:1999-2001.
    PubMed     Text format    


  507. CHIODI F
    Pneumococcal vaccination of HIV-infected young adults is an important global priority.
    AIDS. 2016;30:1991-3.
    PubMed     Text format    


  508. FRIEDMAN EE, Duffus WA
    Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  509. MATEY EJ, Tokoro M, Mizuno T, Matsumura T, et al
    Positive correlation of HIV infection with Giardia intestinalis assemblage B but not with assemblage A in asymptomatic Kenyan children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  510. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  511. BRENNAN AT, Bonawitz R, Gill CJ, Thea D, et al
    A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared to HIV-unexposed uninfected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  512. SHAHMANESH M, Schultze A, Burns F, Kirk O, et al
    The cardiovascular risk management for people living with HIV in Europe: how well are we doing?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  513. STOHR W, Dunn DT, Arenas-Pinto A, Orkin C, et al
    Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy in the PIVOT trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  514. KASSANJEE R, Pilcher CD, Busch MP, Murphy G, et al
    Viral load criteria and threshold optimization to improve HIV incidence assay characteristics - a CEPHIA analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  515. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls: Erratum.
    AIDS. 2016;30:1863.
    PubMed     Text format    



  516. Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use: Erratum.
    AIDS. 2016;30:1861.
    PubMed     Text format    


  517. ROKX C, Vella S, Pantaleo G, Levy Y, et al
    Unite forces to validate biomarkers in the quest for lasting HIV remission.
    AIDS. 2016;30:1859-60.
    PubMed     Text format    


  518. DES JARLAIS DC, Carrieri P
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.
    AIDS. 2016;30:1858-9.
    PubMed     Text format    


  519. CAZEIN F, Pillonel J, Barin F, Jauffret-Roustide M, et al
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.
    AIDS. 2016;30:1857-8.
    PubMed     Text format    


  520. BOYD A, Lacombe K, Girard PM
    An improved understanding of severe liver morbidity in HIV-infected individuals.
    AIDS. 2016;30:1843-5.
    PubMed     Text format    


  521. AHMAD A, Mehraj V, Jenabian MA, Samarani S, et al
    Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.
    AIDS. 2016;30:1839-41.
    PubMed     Text format    


  522. YEK C, Gianella S, Plana M, Castro P, et al
    Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  523. ARPADI SM, Shiau S, Strehlau R, Patel F, et al
    Efavirenz is associated with higher bone mass in South African children with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  524. PARK SY, Mack WJ, Lee HY
    Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  525. CHEW KW, Bhattacharya D
    Virologic and immunologic aspects of HIV-HCV coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  526. EVANS C, Chasekwa B, Ntozini R, Humphrey JH, et al
    Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the pre-ART era.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  527. VOSS JE, Macauley MS, Rogers KA, Villinger F, et al
    Reproducing SIVDeltanef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  528. SAMRI A, Bacchus-Souffan C, Hocqueloux L, Avettand-Fenoel V, et al
    Polyfunctional HIV-specific T-cells in post-treatment controllers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  529. DE MONTEYNARD LA, Matheron S, Gilquin J, Pavie J, et al
    Influence of geographic origin, sex and HIV transmission group on the outcome of first-line combined antiretroviral therapy (cART) in France.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    June 2016
  530. OLIVEIRA M, Ibanescu RI, Pham HT, Brenner B, et al
    The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  531. HONTELEZ JA, Chang AY, Ogbuoji O, Vlas SJ, et al
    Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  532. HARPER K
    The emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland.
    AIDS. 2016.
    PubMed     Text format    


  533. ROBERTSON KR, Miyahara S, Lee A, Brown TT, et al
    Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  534. DUARTE F, Miranda AC, Peres S, Diogo I, et al
    Transmitted drug resistance in drug-naive HIV-2 infected patients.
    AIDS. 2016;30:1687-8.
    PubMed     Text format    


  535. GERVASONI C, Minisci D, Meraviglia P, Baldelli S, et al
    Determinants of bone diseases in tenofovir-treated HIV patients.
    AIDS. 2016;30:1686-7.
    PubMed     Text format    


  536. HAGAN H, Jordan AE, Cleland CM
    Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply.
    AIDS. 2016;30:1685.
    PubMed     Text format    


  537. MOOG C, Mayr L, Tolstrup M
    New insights on the phenotype of HIV reservoirs.
    AIDS. 2016;30:1675-6.
    PubMed     Text format    


  538. MAKUMBI FE, Ssempijja V, Sekasanvu J, Ssekubugu R, et al
    Postcoital penile washing and the risk of HIV acquisition in uncircumcised men.
    AIDS. 2016;30:1669-73.
    PubMed     Text format     Abstract available


  539. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


  540. MOLDT B, Le KM, Carnathan DG, Whitney JB, et al
    Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.
    AIDS. 2016;30:1543-51.
    PubMed     Text format     Abstract available


  541. KOJIMA N, Davey DJ, Klausner JD
    Pre-exposure prophylaxis for human immunodeficiency virus and sexually transmitted infection acquisition among men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  542. LESKO CR, Edwards JK, Moore RD, Lau B, et al
    A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of injection drug use.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  543. FITCH KV, DeFilippi C, Christenson R, Srinivasa S, et al
    Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  544. DELVA W, Leventhal GE, Helleringer S
    Connecting the dots: network data and models in HIV epidemiology.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  545. AMU S, Fievez V, Nozza S, Lopalco L, et al
    Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 Infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  546. YONG YK, Shankar EM, Solomon A, Spelman T, et al
    Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  547. GARCIA M, Le Moal G, Godet C, Beraud G, et al
    First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
    AIDS. 2016;30:1487-8.
    PubMed     Text format    


  548. KADEDE K, Ruel T, Kabami J, Ssemmondo E, et al
    Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  549. MUMMERT C, Hofmann C, Huckelhoven AG, Bergmann S, et al
    T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  550. VAN DEN KERKHOF TL, van Gils MJ, Boeser-Nunnink BD, Burger JA, et al
    Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  551. FERGUSON D, Clarke S, Berry N, Almond N, et al
    Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    May 2016
  552. GIROMETTI N, Jones R, Levy J, McCormack S, et al
    Risks and benefits of HIV pre exposure prophylaxis with tenofovir/emtricitabine in an older man with co-morbidities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  553. JIN C, Peng X, Liu F, Cheng L, et al
    Interferon-induced SAMHD1 expression in astrocytes and microglia is mediated by miR-181a.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  554. KAGAAYI J, Kong X, Kigozi G, Ssekubugu R, et al
    Self-selection of male circumcision clients and behaviors following circumcision in a service program in rakai, Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  555. LONGENECKER CT, Sattar A, Gilkeson R, Mccomsey GA, et al
    Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  556. MONROE AK, Haberlen SA, Post WS, Palella FJ Jr, et al
    Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and-uninfected men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  557. AKGUN KM, Tate JP, Oursler KK, Crystal S, et al
    Association of chronic obstructive pulmonary disease (COPD) with frailty measurements in HIV-infected and uninfected Veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  558. NGUYEN TP, Shukla S, Asaad R, Freeman ML, et al
    Responsiveness to IL-7 but not to IFN-alpha is diminished in CD4 T cells from treated HIV infected patients who experience poor CD4 T cell recovery.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  559. ASAHCHOP EL, Akinwumi SM, Branton WG, Fujiwara E, et al
    Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  560. BREY FL, Seybold U, Kollan C, Bogner JR, et al
    Accelerated CD4 decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  561. KOZLOWSKI HN, Lai ET, Havugimana PC, White C, et al
    Extracellular histones identified in crocodile blood inhibit in vitro HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  562. WAMALWA D, Benki-Nugent S, Langat A, Tapia K, et al
    Treatment interruption after 2-year antiretroviral treatment (ART) initiated during acute/early HIV in infancy: a randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  563. OKULICZ JF, Boufassa F, Costagliola D, Ganesan A, et al
    Cancers In Elite Controllers: Appropriate Follow-up is Essential.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  564. VASE MO, Ludvigsen M, Bendix K, Hamilton-Dutoit S, et al
    Proteomic profiling of pre-treatment serum from HIV infected patients identifies candidate markers predictive of lymphoma development.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  565. HSU DC, Ma YF, Hur S, Li D, et al
    Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  566. CHEN P, Yi Z, Zhang W, Klotman ME, et al
    HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2 driven CD4+ T cell chemotactic response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  567. JASKIEWICZ W, Oketcho V, Settle D, Frymus D, et al
    Investing in the health workforce to increase access to and use of HIV and AIDS services in Uganda.
    AIDS. 2016.
    PubMed     Text format    


  568. ANGLEWICZ P, VanLandingham M, Manda-Taylor L, Kohler HP, et al
    Migration and HIV infection in malawi: A population-based longitudinal study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  569. JEAN K, Puren A, Cutler E, Singh B, et al
    Level of Viral Suppression and the Cascade of HIV Care in a South-African Semi-urban Setting in 2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  570. CROWELL TA, Phanuphak N, Pinyakorn S, Kroon E, et al
    Virologic failure is uncommon after treatment initiation during acute HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  571. BACHLE SM, Malone DF, Buggert M, Karlsson AC, et al
    Elevated levels of iNKT cell and NK cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    April 2016
  572. FIORE JR, Zoboli F, Di Stefano M, Faleo G, et al
    Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
    AIDS. 2016;30:1144-6.
    PubMed     Text format    


  573. ALVAREZ-ROMAN MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, et al
    Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
    AIDS. 2016;30:1141-2.
    PubMed     Text format    


    January 2016
  574. JANI IV, Quevedo JI, Tobaiwa O, Bollinger T, et al
    Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting.
    AIDS. 2016;30:159-61.
    PubMed     Text format    


  575. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    PubMed     Text format     Abstract available


  576. OLSTHOORN AV, Sivachandran N, Bogoch I, Kwantampora J, et al
    Barriers to the uptake of postexposure prophylaxis among Nairobi-based female sex workers.
    AIDS. 2016;30:99-103.
    PubMed     Text format     Abstract available


  577. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    PubMed     Text format     Abstract available


  578. SCHURMANN D, Sobotha C, Gilmartin J, Robberechts M, et al
    A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
    AIDS. 2016;30:57-63.
    PubMed     Text format     Abstract available


  579. SAVAGE EJ, Lowndes CM, Sullivan AK, Back DJ, et al
    Effect of nondisclosure of HIV status in sexual health clinics on unlinked anonymous HIV prevalence estimates in England, 2005-2009.
    AIDS. 2016;30:145-9.
    PubMed     Text format     Abstract available


  580. CHOW FC, Boscardin WJ, Mills C, Ko N, et al
    Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
    AIDS. 2016;30:45-55.
    PubMed     Text format     Abstract available


  581. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    PubMed     Text format     Abstract available


    September 2015
  582. KOETHE JR, Grome H, Jenkins CA, Kalams SA, et al
    The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: